Le produit a bien été ajouté au panier.

discount label
LCBiot-VPWMEPAYQRFL-OH
Vue en 3D

Biosynth logo

LCBiot-VPWMEPAYQRFL-OH

Ref. 3D-PP43120

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le jeudi 12 décembre 2024

Informations sur le produit

Nom :
LCBiot-VPWMEPAYQRFL-OH
Synonymes :
  • LCBiot-Val-Pro-Trp-Met-Glu-Pro-Ala-Tyr-Gln-Arg-Phe-Leu-OH
Description :

Peptide LCBiot-VPWMEPAYQRFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-VPWMEPAYQRFL-OH include the following: Peptide 18-4/chlorin e6-conjugated polyhedral oligomeric silsesquioxane nanoparticles for targeted photodynamic therapy of breast cancer YJ Kim, HI Lee, JK Kim, CH Kim , YJ Kim - Colloids and Surfaces B , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S092777652030059X Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy W Mohammed-Saeid, R Soudy, R Tikoo, K Kaur - 2018 - digitalcommons.chapman.eduhttps://digitalcommons.chapman.edu/pharmacy_articles/607/ Design and evaluation of gemini surfactant-based lipoplexes modified with cell-binding peptide for targeted gene therapy in melanoma model W Mohammed-Saeid , R Soudy - of Pharmacy & , 2018 - journals.library.ualberta.cahttps://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/30010 Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets V Tolmachev , A Orlova - Current medicinal chemistry, 2010 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2010/00000017/00000024/art00004 Characterization and development of a peptide (p160) with affinity for neuroblastoma cells V Askoxylakis , W Mier , S Zitzmann - Journal of Nuclear , 2006 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/47/6/981.short Preclinical evaluation of the breast cancer cell-binding peptide, p160 V Askoxylakis , S Zitzmann, W Mier , K Graham - Clinical cancer , 2005 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/11/18/6705/185959 Characterisation and in vitro and in vivo evaluation of a breast cancer cell-and neuroblastoma cell binding peptide (p160), identified through phage display V Askoxylakis - 2007 - archiv.ub.uni-heidelberg.dehttps://archiv.ub.uni-heidelberg.de/volltextserver/7625/1/ve_Sep13_141530.pdf Design, synthesis, and validation of an in vitro platform peptide-whole cell screening assay using MTT reagent S Ahmed, K Kaur - Journal of Taibah University for Science, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1658365516300802 Breast cancer targeting peptide binds keratin 1: a new molecular marker for targeted drug delivery to breast cancer R Soudy, H Etayash , K Bahadorani - Molecular , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b00652 Peptides targeting HER2-positive breast cancer cells and applications in tumor imaging and delivery of chemotherapeutics PA Cavallaro, M De Santo, EL Belsito, C Longobucco - Nanomaterials, 2023 - mdpi.comhttps://www.mdpi.com/2079-4991/13/17/2476 Therapeutic cancer targeting peptides OH Aina, TC Sroka, ML Chen - Peptide Science: Original , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bip.10257 Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel M Shahin, S Ahmed, K Kaur , A Lavasanifar - Biomaterials, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961211003590 Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin M Shahin, R Soudy, H El-Sikhry, JM Seubert , K Kaur - Cancer letters, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304383512005952 Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer M Azari, F Bahreini , VN Uversky , N Rezaei - Biochemical Pharmacology, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006295223000503 Combinatorial discovery of tumor targeting peptides using phage display LA Landon, SL Deutscher - Journal of cellular biochemistry, 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.10634 Development of Novel Peptide-Doxorubicin Conjugates for Targeting Triple-Negative Breast Cancer A Saghaeidehkordi - 2021 - search.proquest.comhttps://search.proquest.com/openview/0a7f923b82b25109d646e28de819bb53/1?pq-origsite=gscholar&cbl=18750&diss=y

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP43120 LCBiot-VPWMEPAYQRFL-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".